Recombinant Human NEK7 Protein，His & SUMO

NEK7, a member of the NIMA-related kinase (NEK) family, has garnered significant attention in recent years due to its crucial role in various cellular processes, including cell cycle regulation, mitosis, and cytokinesis. The research surrounding NEK7 focuses on its involvement in the activation of the NLRP3 inflammasome, a critical component of the innate immune response. Activation of the NLRP3 inflammasome is associated with the release of pro-inflammatory cytokines, which are implicated in various inflammatory diseases, metabolic disorders, and cancer. Given its pivotal role in these processes, NEK7 has emerged as a potential therapeutic target for inflammatory diseases. Researchers are particularly interested in its reconstitution and characterization as a recombinant protein to better understand its biochemical properties and functional mechanisms. The study of NEK7 as a recombinant protein aims to elucidate its structure-function relationships, allowing for the development of specific inhibitors or modulators that could be used in clinical settings. Additionally, understanding NEK7's interaction with other proteins in the inflammasome pathway is essential for developing strategies to manipulate immune responses, providing insight into potential interventions for treating diseases characterized by excessive inflammation. This research is critical for advancing our knowledge in the fields of cell biology, immunology, and therapeutic development, positioning NEK7 as a key player in the intersection of cancer biology and inflammation.